MIST — Milestone Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $236.51m
- $187.74m
- $1.55m
Annual cashflow statement for Milestone Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -42.9 | -58.4 | -59.7 | -41.5 | -63.1 |
| Depreciation | |||||
| Non-Cash Items | 7.28 | 9.09 | 11.9 | 8.91 | 11.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.26 | -3.26 | 1.24 | 3.66 | 2.68 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -33.2 | -52.5 | -46.4 | -28.8 | -49 |
| Capital Expenditures | — | -0.272 | -0.112 | -0.033 | -0.302 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 70 | -56.9 | 4.87 | 8.32 | 11.5 |
| Acquisition of Business | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 70 | -57.1 | 4.76 | 8.28 | 11.2 |
| Financing Cash Flow Items | — | — | -2.79 | 4.62 | 2.57 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.05 | 3.09 | 47.8 | 32.1 | 85.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 41.8 | -107 | 6.12 | 11.6 | 47.7 |